Determinants of Orphan Drugs Prices in France: A Regression Analysis

Orphanet Journal of Rare Diseases - United Kingdom
doi 10.1186/s13023-016-0561-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Psy60 - Orphan Versus Ultra-Orphan Drugs Prices in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy150 - Inequity of Orphan Drugs Prices in Europe

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy75 - Is Disease Area a Determinant of Orphan Drugs Prices？

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy59 - Orphan Drugs Prices Comparison in Middle East North Africa (Mena) Region

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PHP46 Market Uptake of Orphan Drugs – A European Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Determinants of Deprivation in Turkey, a Logistic Regression Analysis

Studia Mundi - Economica
2019English

Psy131 - Access to Orphan Drugs (Od) in Spain: Analysis of Nusinersen’s Case

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Shortage of Drugs in France

Nature
Multidisciplinary
1942English

Orphan Drug Pricing in France: Influence of Main Factors

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy